Valproate-induced eosinophilia in children with epilepsy: Role of interleukin-5

Journal of Child Neurology

Volumn 20, Issue 2, 2005, Pages 150-152

  Makis, Alexandros C ^a,d   Tzoufi, Meropi ^b   Kateri, Maria D ^c   Bourantas, Konstantinos L ^b   Papadopoulou, Zoe L ^b  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY OF PIRAEUS   (Greece)

^d NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; INTERLEUKIN 5; VALPROIC ACID;

ABSENCE; ADOLESCENT; ANTICONVULSANT ACTIVITY; ARTICLE; ATONIC SEIZURE; BENIGN CHILDHOOD EPILEPSY; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INDUCED DISEASE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FEMALE; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATHOGENESIS; PRIORITY JOURNAL; TONIC CLONIC SEIZURE;

EID: 16844364394     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738050200022201     Document Type: Article

References (30)

1. Neville BG: Epilepsy in childhood. BMJ 1997;315:924-930.
2. Jimenez-Rodriguezvila M, Caro-Paton A, Conde M et al: Side-effects of sodium valproate, mainly related to its hepatic and pancreatic toxicity. Int J Clin Pharmacol Res 1986;6:217-224.
3. Rothenberg ME: Mechanisms of disease: Eosinophilia. N Engl J Med 1998;338:1592-1600.
4. Kaufman J, O'Shaughnessy IM: Eosinophilic pleural effusion associated with valproic acid administration. South Med J 1995;88:881-882.
5. Simon HU, Blaser K: Inhibition of programmed eosinophil death: A key pathogenic event for eosinophilia? Immunol Today 1995;16:53-55.
6. Sanderson CJ: Interleukin-5, eosinophils, and disease. Blood 1992;79:3101-3109.
7. Gleich GJ, Adolphson CR: The eosinophilic leukocyte: Structure and function. Adv Immunol 1986;39:177-253.
8. Capron M: Eosinophils and parasites. Ann Parasitol Hum Comp 1991;66(Suppl 1):41-45.
9. Spry CJF: Eosinophils: A Guide to the Scientific and Medical Literature. Oxford, UK, Oxford University Press, 1988.
10. Mehler MF, Rozental R, Dougherty M, et al: Cytokine regulation of neuronal differentiation of hippocampal progenitor cells. Nature 1993;362:62-65.
11. Schobitz B, De Kloet ER, Holsboer: Gene expression and function of interleukin-6 and tumor necrosis factor in the brain. Prog Neurobiol 1994;44:397-402.
12. Hopkins SJ, Rothwell NJ: Cytokines and the nervous system I: Expression and recognition. Trends Neurosci 1995;18:83-88.
13. Macdonald PL, Kelly KM: Antiepileptic drug mechanisms of action. Epilepsia 1993;34(Suppl 5):S1-S8.
14. McLean MJ, Macdonald RL: Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 1986;237:1001-1011.
15. Fujiwara K, Yoshida M, Ochi M, et al: Serum immunoglobulin levels in children receiving valproic acid. Brain Dev 1983;5:199-203.
16. Joubert PH, Aucamp AK, Potgieter GM, Verster F: Epilepsy and IgA deficiency - The effect of sodium valproate. S Afr Med J 1977;52: 642-644.
17. Queiroz ML, Mullen PW. Effects of sodium valproate on the immune response. Int J Immunopharmacol 1992;14:392-396.
18. Ichiyama T, Okada K, Lipton JM et al: Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res 2000;857:246-251.
19. Wong ML, Licinio J: Localization of stem cell factor mRNA in adult rat hippocampus. Neuroimmunomodulation 1994;1:181-187.
20. Wong ML, Al-Shekhlee A, Gold PW, Licinio J: Cytokines in the brain, in Rothwell NJ (ed): Cytokines in the Nervous System. Georgetown, TX, Landers Bioscience Publishers, 1996, 3-20.
21. Pacifici R, Paris L, Di Carlo S, et al: Cytokine production in blood mononuclear cells from epileptic patients. Epilepsia 1995;36:384-387.
22. Rothwell NJ: Cytokines - Killers in the brain? J Physiol 1999;514:13-17.
23. Allan SM, Parker LC, Collins B, et al: Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat. Proc Natl Acad Sci U S A 2000;97:5580-5585.
24. Loddick SA, Rothwell NJ: Mechanisms of tumor necrosis factor-α action on neurodegeneration: Interaction with insulin-like growth factor-1. Proc Natl Acad Sci U S A 1999;96:9449-9451.
25. McNamara JO: Cellular and molecular basis of epilepsy. J Neurosci 1994;14:3413-3425.
26. Giulian D, Li J, Li X, et al: The impact of microglia-derived cytokines upon gliosis in the CNS. Dev Neurosci 1994;16:128-136.
27. Barna BP, Estes ML, Jacobs BS, et al: Human astrocytes proliferate in response to tumor necrosis factor alpha. J Neuroimmunol 1990;30:239-243.
28. Sawada M, Suzumura A, Itoh Y, Marunouchi T: Production of interleukin-5 by mouse astrocytes and microglia in culture. Neurosci Lett 1993;155:175-178.
29. Awatsuji H, Furukawa Y, Hirota M, et al: Interleukin-4 and -5 as modulators of nerve growth factor synthesis/secretion in astrocytes. J Neurosci Res 1993;34:539-545.
30. Ringheim GE: Mitogenic effects of interleukin-5 on microglia. Neurosci Lett 1995;8:131-134.